Skip to content

The effects of exercise intervention on tobacco withdrawal symptoms (TWS) in smokers

The effects of exercise intervention on tobacco withdrawal symptoms in smokers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015102121543N2
Enrollment
80
Registered
2016-01-25
Start date
2016-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

smoker and sedentary.

Interventions

Intervention 1: Intervention group is an exercise training , 3 times per week, for 2 month running on treadmill with moderate intensity (64-77% HR max) and need to maintain smoking habit. Intervent
Lifestyle
Intervention group is an exercise training , 3 times per week, for 2 month running on treadmill with moderate intensity (64-77% HR max) and need to maintain smoking habit
control group no exercise but need to maintain their sedentary lifestyle and smoking habit

Sponsors

Ministry Of Higher Education, Malaysia
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: inclusions criteria Male smokers;who smoke at least 10 cigarettes per day at least for the past 2 years; who have sedentary lifestyle is determining by use of IPAQ (International Physical Activity Questionnaire) ;aged between 20-45 year old;categorized as low and moderate risks by ACSM recommendations identified by AHA/ACSM ; Preparticipation Screening Questionnaires;who are in the pre-contemplation stage ; who are systolic blood pressure around 90-140 mmHg and diastolic around 60-90mmHg; who are body mass index (BMI) less than 30 kg/m2; who are fasting blood cholesterol not more than 200 mg/dl; who are fasting blood glucose not more than 100mg/dL and who are willing to comply with the study’s protocol Exclusion who smoke more than 20 cigarette; who are categorized as high risk by ACSM recommendation ;who have cardiovascular diseases ;who have psychiatry problems or on medication; who face psychotherapy or pharmacotherapy for smoking cessation ; who are depressed ; who are hallucinogens /drug/opioid dependent for the past 6 months; who are on a treatment of anxiety/mood disorder ; who have hypertension =140 systolic blood pressure and =90 diastolic blood pressure; who are fasting blood cholesterol level =200mg/dl or medical treatment with lipid abnormalities; who are obese (=30kg/m2); who have orthopaedic problem ;who take alcohol

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Tobacco withdrawal symptoms. Timepoint: before training, after 2 month training and after 2 weeks of detraining in 12 hours of overnight abstinent. Method of measurement: using Wiscounsin Scale withdrawal symptom (WSWS)questionnaire.;Irritability. Timepoint: before training, after 2 month training and after 2 weeks of detraining in 12 hours of overnight abstinent. Method of measurement: blood pressure and temperature.;Quality of sleep. Timepoint: before training, after 2 month training and after 2 weeks of detraining in 12 hours of overnight abstinent. Method of measurement: Pittsburgh Sleep Quality index (PSQI).;Smoking urge. Timepoint: before training, after 2 month training and after 2 weeks of detraining in 12 hours of overnight abstinent. Method of measurement: question of smoking urge (brief QSU).;Mood. Timepoint: before training, after 2 month training and after 2 weeks of detraining in 12 hours of overnight abstinent. Method of measurement: profile mood state (POMS).

Secondary

MeasureTime frame
Cortisol, adrenalin and beta endorphin. Timepoint: before training, after training and after 2 weeks of detraining. Method of measurement: blood.

Countries

Malaysia

Contacts

Public ContactSiti Munira Yasin

Universiti Teknologi MARA, Sg Buloh

smunira@salam.uitm.edu.my001761267737

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026